DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Porter C, Armstrong-Fisher S, Kopotsha T. et al.
Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer.
J Reprod Immunol 2016;
116: 7-12
DOI: 10.1016/j.jri.2016.04.284.
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.